OPEXA THERAPEUTICS
Opexa Therapeutics, Inc. (NASDAQ:OPXA) is a publicly traded biotechnology company dedicated to the development of patient-specific immunotherapies for the treatment of multiple sclerosis. The Company’s leading therapy candidate, Tcelna™, is a personalized T-cell immunotherapy in a Phase IIb clinical development program (the Abili-T trial) for the treatment of Secondary Progressive Multiple Sclerosis. Opexa’s mission is to lead the field of Precision Immunotherapy™ by aligning the interests of patients, employees and shareholders. Opexa is located in The Woodlands, Texas north of Houston on one acre of forested land and houses its cGMP facility, research laboratories and corporate offices.
OPEXA THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
1986-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.opexatherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(281) 272-9331
Total Funding:
5.84 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Font Awesome Domain Not Resolving Apache Mobile Non Scaleable Content CPanel SSL One.com DNS SingleHop
Similar Organizations
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Employees Featured
Karthik Radhakrishnan Chief Financial Officer @ Opexa Therapeutics
Chief Financial Officer
David Jorden Bord of Directors @ Opexa Therapeutics
Bord of Directors
Jingwu Zang Scientific Founder @ Opexa Therapeutics
Scientific Founder
Founder
Stock Details
Official Site Inspections
http://www.opexatherapeutics.com
- Host name: cphost23.qhoster.net
- IP address: 104.243.33.214
- Location: Miami United States
- Latitude: 25.8119
- Longitude: -80.2318
- Metro Code: 528
- Timezone: America/New_York
- Postal: 33142
More informations about "Opexa Therapeutics"
About Opexa - About Opexa - Opexa Therapeutics
Opexa Therapeutics, Inc. (NASDAQ:OPXA) is a publically traded biotechnology company developing a personalized immunotherapy with the potential to treat major illnesses, including …See details»
Opexa Therapeutics
2/11/2021 - 2:30am EST "The 15th Annual BIO CEO & Investor Conference". 2/05/2022 - 8:30am EST Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for …See details»
Opexa Therapeutics - Crunchbase Company Profile
Contact Email info@opexatherapeutics.com Phone Number (281) 272-9331 Opexa Therapeutics, Inc. (NASDAQ:OPXA) is a publicly traded biotechnology …See details»
Opexa Therapeutics - LinkedIn
Opexa Therapeutics | 1,198 followers on LinkedIn. Opexa Therapeutics, Inc. (NASDAQ:OPXA) is a publicly traded biotechnology company dedicated to the development of personalized …See details»
Opexa Therapeutics Company Profile 2024: Valuation, …
Opexa Therapeutics General Information Description. Provider and developer of patient-specific cellular therapies intended for the treatment of autoimmune diseases. The company's personalized cellular immunotherapy treatment is in …See details»
Opexa Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Jun 20, 2023 Explore Opexa Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 4 news, Disease Domain:Nervous System Diseases ...See details»
Opexa Therapeutics, Inc. | MedPath
First Posted Date 2012-09-13 Last Posted Date 2017-01-10 Lead Sponsor Opexa Therapeutics, Inc. Target Recruit Count 183 Registration Number NCT01684761See details»
Opexa Therapeutics - Company Profile - Tracxn
Oct 30, 2024 Opexa Therapeutics - Developing personalized T-cell therapies to treat autoimmune diseases, including multiple sclerosis.. Acquired by Acer Therapeutics. Raised a …See details»
Opexa Therapeutics
Info@opexatherapeutics.com. About Opexa. Opexa Therapeutics, Inc. (NASDAQ:OPXA) is a publicly traded biotechnology company dedicated to the development of patient-specific …See details»
Opexa Therapeutics - Company Profile & Staff Directory
Opexa Therapeutics, Inc. (NASDAQ:OPXA) is a publicly traded biotechnology company dedicated to the development of personalized immunotherapies with the potential to treat major illnesses, …See details»
Opexa Therapeutics, Inc. - VentureRadar
Opexa Therapeutics, Inc. VentureRadar profile. Find out more about Opexa Therapeutics, Inc., Cell Therapies and Major Pharmaceuticals.See details»
Opexa Therapeutics - Products, Competitors, Financials, Employees ...
Headquarters Location. 2635 N Crescent Ridge Drive . The Woodlands, Texas, 77381, United States. 281-272-9331See details»
Opexa Therapeutics, Inc. | Insights
Nov 15, 2017 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Opexa Facility Becomes Foundation for Contract Manufacturing …
Feb 1, 2022 THE WOODLANDS, Texas (February 1, 2022) - Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biopharmaceutical company with a strong history of cellular therapy drug …See details»
Opexa Therapeutics Management Team | Org Chart - RocketReach
Opexa Therapeutics employs 23 employees. The Opexa Therapeutics management team includes Marianne Pfeil (Quality Control Laboratory Technician), Maika Schuster (User …See details»
Opexa Therapeutics, Inc. - VentureRadar
Similar Companies: Bellicum Pharmaceuticals USA Publicly Traded Bellicum is dedicated to developing safer and more effective cell therapies to treat cancers and other serious, life …See details»
Opexa Therapeutics Overview | SignalHire Company Profile
Phone Number: 281-775-0600: Opexa Therapeutics industries Biotech: Headquarters Location: Opexa Therapeutics, Inc.,See details»
Operational excellence in biopharma research and early …
9 hours ago Training talent to be innovative should extend beyond core skill sets to enable sound judgment for trade-off decisions. Asset teams should prioritize activities by evaluating …See details»
Opexa Therapeutics - About Opexa - Management Team
Dr. Healey has over 25 years experience in cellular immunology and immune regulation in both academic and biotech environments. Prior to joining Opexa in April 2010, Dr. Healey was …See details»
Opexa Therapeutics-动脉网 - vbdata.cn
Opexa Therapeutics, Inc.（纳斯达克股票代码：OPXA）是一家上市的生物技术公司，开发个性化免疫疗法，用于治疗多发性硬化症（MS）以及其他自身免疫性疾病，如视神经脊髓 …See details»